DPP-4 inhibitors and glucose homeostasis - From cell to bedside / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 525-526, 2012.
Article
in Zh
| WPRIM
| ID: wpr-427241
Responsible library:
WPRO
ABSTRACT
Type 2 Diabetes is the consequence of the disturbances of both α- and β-cell secretions.Glucagon-like peptide-1 ( GLP-1 ),which regulates the function of alpha and beta cells,has led to the emergence of a new class of oral anti-diabetic drugs.DPP-4 inhibitors,which increase the concentration of GLP-1 and consequently improve HbAlC,have become a choice for patients in different stages of diabetes.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Endocrinology and Metabolism
Year:
2012
Type:
Article